Dynamic thiol/disulphide homeostasis before and after radical prostatectomy in patients with prostate cancer

Abstract Thiol groups are important anti-oxidants and essential molecules protecting organism against the harmful effects of reactive oxygen species (ROS). The aim of our study is to evaluate thiol–disulphide homeostasis with a novel recent automated method in patients with localized prostate cancer (PC) before and six months after radical prostatectomy (RP). 18 patients with PC and 17 healthy control subjects were enrolled into the study. Blood samples were collected from the controls subjects and patients before and six months after RP. Thiol–disulphide homeostasis was determined using a recently developed novel method. Prostate-specific antigen (PSA), albumin, total protein, total thiol, native thiol, disulphide and total antioxidant status (TAS) were measured and compared between the groups. Native thiol, total thiol and TAS levels were significantly higher in the control group than the patients before RP (p < .001). There was a non-significant increase in the native thiol, total thiol and TAS levels in the patients six months after RP in comparison to the levels before RP (p values .3, .3 and .09, respectively). We found a significant negative correlation between PSA and thiol levels. Our study demonstrated that the decreased thiol and TAS levels weakened anti-oxidant defence mechanism in the patients with PC as indicated. Increased oxidative stress in prostate cancer patients may cause metabolic disturbance and have a role in the aetiopathogenesis of prostate cancer.

[1]  Michael Gronow,et al.  Determination of cellular glutathione:glutathione disulfide ratio in prostate cancer cells by high performance liquid chromatography with electrochemical detection. , 2016, Journal of chromatography. A.

[2]  O. Erel,et al.  Oxidative Stress and Periodontal Disease in Obesity , 2016, Medicine.

[3]  O. Erel,et al.  Dynamic thiol/disulphide homeostasis in patients with newly diagnosed primary hypertension. , 2016, Journal of the American Society of Hypertension : JASH.

[4]  M. Comini Measurement and meaning of cellular thiol:disufhide redox status , 2016, Free radical research.

[5]  F. Zorlu,et al.  Predictive factors for biochemical recurrence in radical prostatectomy patients , 2015, Central European journal of urology.

[6]  O. Erel,et al.  How does thiol/disulfide homeostasis change in prediabetic patients? , 2015, Diabetes research and clinical practice.

[7]  Xinghuan Wang,et al.  Oxidative stress measured by thioredoxin reductase level as potential biomarker for prostate cancer. , 2015, American journal of cancer research.

[8]  M. Rubens,et al.  Selenium and vitamin E for prostate cancer--justifications for the SELECT study. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[9]  S. Gangemi,et al.  Oxidative Stress in Benign Prostatic Hyperplasia: A Systematic Review , 2014, Urologia Internationalis.

[10]  O. Erel,et al.  A novel and automated assay for thiol/disulphide homeostasis. , 2014, Clinical biochemistry.

[11]  C. Kuo,et al.  Intracellular Glutathione Depletion by Oridonin Leads to Apoptosis in Hepatic Stellate Cells , 2014, Molecules.

[12]  W. Zhong,et al.  Increasing discordant antioxidant protein levels and enzymatic activities contribute to increasing redox imbalance observed during human prostate cancer progression. , 2014, Free radical biology & medicine.

[13]  Klaus-Peter Adam,et al.  Cysteine Catabolism: A Novel Metabolic Pathway Contributing to Glioblastoma Growth , 2013, Cancer research.

[14]  Rafael Radi,et al.  The thiol pool in human plasma: the central contribution of albumin to redox processes. , 2013, Free radical biology & medicine.

[15]  M. Smeyne,et al.  Glutathione metabolism and Parkinson's disease. , 2013, Free radical biology & medicine.

[16]  J. Mieyal,et al.  Protein-thiol oxidation and cell death: regulatory role of glutaredoxins. , 2012, Antioxidants & redox signaling.

[17]  R. Pecoits-Filho,et al.  Plasma Cysteine/Cystine Reduction Potential Correlates with Plasma Creatinine Levels in Chronic Kidney Disease , 2012, Blood Purification.

[18]  Jian-Min Yuan,et al.  Green and black tea intake in relation to prostate cancer risk among Singapore Chinese , 2012, Cancer Causes & Control.

[19]  Dean P. Jones,et al.  Cysteine/cystine redox signaling in cardiovascular disease. , 2011, Free radical biology & medicine.

[20]  Yücel Şahin,et al.  Determination of oxidant stress in plasma of rheumatoid arthritis and primary osteoarthritis patients. , 2010, Indian journal of biochemistry & biophysics.

[21]  E. Matteucci,et al.  Thiol Signalling Network with an Eye to Diabetes , 2010, Molecules.

[22]  N. Matevska,et al.  Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer. , 2009, Clinical biochemistry.

[23]  M. Srougi,et al.  Pretreatment Tumor Volume Estimation Based on Total Serum PSA in Patients with Localized Prostate Cancer , 2008, Clinics.

[24]  R. D. Mittal,et al.  Free radical injury and antioxidant status in patients with benign prostate hyperplasia and prostate cancer , 2005, Indian Journal of Clinical Biochemistry.

[25]  N. Baral,et al.  Oxidative stress in benign prostate hyperplasia. , 2007, Nepal Medical College journal : NMCJ.

[26]  E. Vazquez,et al.  Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer , 2007, British Journal of Cancer.

[27]  A. Aydın,et al.  Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. , 2006, Clinical biochemistry.

[28]  O. Erel,et al.  A novel automated method to measure total antioxidant response against potent free radical reactions. , 2004, Clinical biochemistry.

[29]  Dean P. Jones,et al.  Glutathione redox potential in response to differentiation and enzyme inducers. , 1999, Free radical biology & medicine.

[30]  G. Aykaç-toker,et al.  Antioxidant enzyme activities and lipid peroxides in the plasma of patients with benign prostatic hyperplasia or prostate cancer are not predictive , 1999, Journal of Cancer Research and Clinical Oncology.

[31]  L. Oberley,et al.  Expression of antioxidant enzymes in human prostatic adenocarcinoma , 1997, The Prostate.

[32]  G. Wilding,et al.  Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. , 1997, Journal of the National Cancer Institute.